September 11th 2024
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.
September 10th 2024
Tailored Diabetes Care: Customizing Management Strategies Across Life Stages
June 27th 2024Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.
Key Insights and Practical Tips: Wisdom from UCSD Practitioners for Effective T1D Management
The panel of experts from UCSD concludes the discussion on delaying the onset of stage 3 T1D by providing key takeaways and clinical advice on the treatment of patients with this condition.
Teplizumab Infusion Protocol: Clinical Processes and Strategies for Infusion Access Enhancement
Focusing on the utilization of teplizumab, the expert panel from UCSD shares insights in how to select patients for this treatment and provide practical tips for the infusion process, and infusion location options.
Exploring the TN-10 Teplizumab Clinical Trial: Patient Demographics and Efficacy Insights
The panel reviews the TN-10 trial investigating teplizumab, focusing on patient inclusion criteria, patient outcomes, and adverse reactions.
Understanding Autoantibody Screening Tests: Methods, Interpretation, and Analysis Practicalities
Schafer Boeder, MD and Andrea Stallings, PA delve into the intricacies of autoantibody screening tests for T1D with detailed insights on their methodologies, interpretation nuances, and practical analysis considerations.
Following a couple of audience polling questions, Andrea Stallings, PA and her UCSD colleagues, comment on identifying suitable candidates for T1D screening, understanding autoantibodies involved in this condition, and determining when to rescreen those at risk for disease progression.
The Crucial Impact of Early Intervention in Preventing T1D Stage Progression
Addressing the significance of acting early in T1D care, a group of diabetes experts delve into the impact of delaying intervention during stage 2 of the condition.
Schafer Boeder, MD and his colleagues provide a comprehensive overview of the stages of T1D in patients with diabetes, highlighting the various signs and symptoms associated with each stage.
Insights into the Burden of T1D: Genetic Links and Familial Considerations from UCSD Practitioners
A panel of experts on diabetes management introduce themselves and provide an overview of the condition, highlighting risk factors, disease burden, and the benefits of collaborative care.
Expert Insights: Patient Case Studies & Key Takeaways on T2D Management in Older Patients
May 23rd 2024Medha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, discuss older adult patient cases and review their respective treatment approaches, sharing final takeaways to provide practical insights for managing diabetes in this patient population.
Streamlining Treatment: Insights from Experts on Simplifying Regimens for Older Adult Patients
May 23rd 2024Medical experts discuss the importance of optimizing medication regimens for older patients with diabetes, emphasizing the need to keep treatment plans simple and highlight the value of continuous glucose monitors in monitoring patients and adjusting therapies accordingly.
Decoding Deprescribing: Strategies and Approaches for Rational Medication Reduction
May 23rd 2024Key opinion leaders in the management of diabetes discuss the process of deprescribing, or the process of medication simplification to encourage adherence and ease of regimens in older adult populations with type 2 diabetes.
Community Perspectives: First-Line Treatment Considerations for Older Adults with Type 2 Diabetes
May 23rd 2024Medha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, discuss the current treatment landscape for type 2 diabetes, and highlight key considerations for the selection of first-line treatments for older adults with this condition.
Impact of Geriatric Syndrome in Older Adults with T2D
May 23rd 2024Key opinion leaders in the management of diabetes define and discuss the impact and complexities of geriatric syndromes in older adults with T2D. They shed light on challenges like cognitive impairment, urinary incontinence, and neuropathy, offering insights into effective diabetes management strategies for this demographic.
Defining Older Adults: Highlighting the Age Spectrum and Role of Care Settings
May 23rd 2024Drs Medha Munshi and James Bailey discuss the definition of older adult patients, considering both chronological age and mental and physical state. They underscore the significance of customizing diabetes treatment to accommodate individual patient abilities, rather than solely basing decisions on age
Burden of T2D and Management Considerations for Older and Younger Adults
May 23rd 2024Medha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, delve into the management and burden of type 2 diabetes (T2D). They shed light on the prevalence of the disease in older adults and its potential health impacts as patients age, while also addressing risk factors and considerations for younger patients as they progress in age.